Usana Health Sciences
USNA
177 hedge funds and large institutions have $832M invested in Usana Health Sciences in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 77 increasing their positions, 59 reducing their positions, and 25 closing their positions.
31% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 59
0.68% less ownership
Funds ownership: 54.86% → 54.18% (-0.68%)
7% less funds holding
Funds holding: 191 → 177 (-14)
30% less capital inflows, than outflows
Capital inflows: $48.1M | Capital outflows: $68.6M
48% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pzena Investment Management
New York
|
+$26M |
| 2 |
Vestcor Inc
Fredericton,
New Brunswick, Canada
|
+$2.04M |
| 3 |
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$1.54M |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$1.4M |
| 5 |
Jupiter Asset Management
London,
United Kingdom
|
+$1.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$21.5M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$8.14M |
| 3 |
Heartland Advisors
Milwaukee,
Wisconsin
|
-$6.07M |
| 4 |
CE
Clark Estates
New York
|
-$4.2M |
| 5 |
Goldman Sachs
New York
|
-$3.57M |
USNA Hedge Fund Activity: Q1 2022 in Review
177 of the 6,363 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2022, worth a combined $832M — down 23% from $1.08B a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of USNA and 13 opened new positions — a net loss of 12 holders — while 59 trimmed existing stakes and 77 added.
The largest buyer was Pzena Investment Management, adding an estimated $26M. The largest seller was Wellington Management Group, cutting an estimated $21.5M.
- 177 institutional investors held Usana Health Sciences (USNA) as of Q1 2022, down from 191 in Q4 2021.
- Funds reported $832M of Usana Health Sciences stock for Q1 2022, down 23% quarter-over-quarter.
- 13 funds opened new Usana Health Sciences positions in Q1 2022 and 25 closed out, a net change of -12 holders.
- The largest Usana Health Sciences buyer in Q1 2022 was Pzena Investment Management, an estimated $26M added.
- The largest Usana Health Sciences seller in Q1 2022 was Wellington Management Group, an estimated $21.5M sold.
Based on aggregated 13F filings for Q1 2022.